You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR DEXTROAMPHETAMINE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for DEXTROAMPHETAMINE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000304 ↗	Dextroamphetamine as an Adjunct in Cocaine Treatment - 1	Completed	University of Texas	Phase 2	1997-08-01	The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in cocaine treatment; an evaluation of the ""replacement"" strategy.
NCT00000304 ↗	Dextroamphetamine as an Adjunct in Cocaine Treatment - 1	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1997-08-01	The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in cocaine treatment; an evaluation of the ""replacement"" strategy.
NCT00000305 ↗	Amphetamine Cocaine Interaction Study - 2	Terminated	National Institute on Drug Abuse (NIDA)	Phase 1	1969-12-31	The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.
NCT00000305 ↗	Amphetamine Cocaine Interaction Study - 2	Terminated	University of Texas	Phase 1	1969-12-31	The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.
NCT00000305 ↗	Amphetamine Cocaine Interaction Study - 2	Terminated	The University of Texas Health Science Center, Houston	Phase 1	1969-12-31	The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study.
NCT00000306 ↗	Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3	Completed	University of Texas	Phase 2	1994-09-01	The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in concurrent cocaine and opiate dependent patients.
NCT00000306 ↗	Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1994-09-01	The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in concurrent cocaine and opiate dependent patients.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DEXTROAMPHETAMINE

Condition Name

Chart
Table

Condition Name for DEXTROAMPHETAMINE
Intervention	Trials
Cocaine-Related Disorders	5
Attention Deficit Disorder With Hyperactivity	3
ADHD	3
Narcolepsy	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DEXTROAMPHETAMINE
Intervention	Trials
Disease	9
Attention Deficit Disorder with Hyperactivity	9
Hyperkinesis	6
Cocaine-Related Disorders	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DEXTROAMPHETAMINE

Trials by Country

Map
Table

Trials by Country for DEXTROAMPHETAMINE
Location	Trials
United States	31
Canada	3
Norway	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for DEXTROAMPHETAMINE
Location	Trials
Texas	8
California	5
New York	4
Massachusetts	2
Pennsylvania	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DEXTROAMPHETAMINE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DEXTROAMPHETAMINE
Clinical Trial Phase	Trials
Phase 4	10
Phase 2	13
Phase 1/Phase 2	2
[disabled in preview]	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DEXTROAMPHETAMINE
Clinical Trial Phase	Trials
Completed	23
Terminated	5
Recruiting	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DEXTROAMPHETAMINE

Sponsor Name

Chart
Table

Sponsor Name for DEXTROAMPHETAMINE
Sponsor	Trials
University of Texas	5
National Institute on Drug Abuse (NIDA)	4
New York State Psychiatric Institute	3
[disabled in preview]	10
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DEXTROAMPHETAMINE
Sponsor	Trials
Other	36
NIH	9
Industry	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.